{"nct_id":"NCT04662931","title":"An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2021-07-14","start_date_type":"ACTUAL","primary_completion_date":"2024-02-14","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-14","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}